These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 10406979)

  • 41. Clinical aspects of multiple sclerosis in north-east Scotland with particular reference to its course and prognosis.
    Phadke JG
    Brain; 1990 Dec; 113 ( Pt 6)():1597-628. PubMed ID: 2276037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiological investigations into multiple sclerosis in Southern Hesse. V. Course and prognosis.
    Lauer K; Firnhaber W
    Acta Neurol Scand; 1987 Jul; 76(1):12-7. PubMed ID: 3498287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan.
    Itoh T; Aizawa H; Hashimoto K; Yoshida K; Kimura T; Katayama T; Koyama S; Yahara O; Kikuchi K
    J Neurol Sci; 2003 Oct; 214(1-2):7-9. PubMed ID: 12972381
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late onset multiple sclerosis: concerns in aging patients.
    Lotti CBC; Oliveira ASB; Bichuetti DB; Castro I; Oliveira EML
    Arq Neuropsiquiatr; 2017 Jul; 75(7):451-456. PubMed ID: 28746432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.
    Hirst C; Ingram G; Swingler R; Compston DA; Pickersgill T; Robertson NP
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1137-43. PubMed ID: 18303106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
    Thompson AJ; Kermode AG; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; McDonald WI
    BMJ; 1990 Mar; 300(6725):631-4. PubMed ID: 2138923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.
    Ghezzi A; Bergamaschi R; Martinelli V; Trojano M; Tola MR; Merelli E; Mancardi L; Gallo P; Filippi M; Zaffaroni M; Comi G;
    J Neurol; 2004 Jan; 251(1):47-52. PubMed ID: 14999489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurologic impairment 10 years after optic neuritis.
    Beck RW; Smith CH; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Moke PS; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Trobe JD; Wall M;
    Arch Neurol; 2004 Sep; 61(9):1386-9. PubMed ID: 15364684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis.
    Bergamaschi R; Berzuini C; Romani A; Cosi V
    J Neurol Sci; 2001 Aug; 189(1-2):13-21. PubMed ID: 11535229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
    Alroughani R; Ahmed SF; Al-Hashel J
    Pediatr Neurol; 2015 Dec; 53(6):508-12. PubMed ID: 26383244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early clinical markers of aggressive multiple sclerosis.
    Malpas CB; Manouchehrinia A; Sharmin S; Roos I; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Eichau S; Bergamaschi R; Sola P; Ferraro D; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Grand'Maison F; Ozakbas S; Van Pesch V; Granella F; Hupperts R; Pucci E; Boz C; Sidhom Y; Gouider R; Spitaleri D; Soysal A; Petersen T; Verheul F; Karabudak R; Turkoglu R; Ramo-Tello C; Terzi M; Cristiano E; Slee M; McCombe P; Macdonell R; Fragoso Y; Olascoaga J; Altintas A; Olsson T; Butzkueven H; Hillert J; Kalincik T
    Brain; 2020 May; 143(5):1400-1413. PubMed ID: 32386427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry.
    Kindwall EP; McQuillen MP; Khatri BO; Gruchow HW; Kindwall ML
    Arch Neurol; 1991 Feb; 48(2):195-9. PubMed ID: 1993011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disability progression in multiple sclerosis is slower than previously reported.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.
    Etemadifar M; Nourian SM; Nourian N; Abtahi SH; Sayahi F; Saraf Z; Fereidan-Esfahani M
    J Child Neurol; 2016 Jun; 31(7):932-7. PubMed ID: 26979097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benign multiple sclerosis: a need for a consensus.
    Glad SB; Aarseth JH; Nyland H; Riise T; Myhr KM
    Acta Neurol Scand Suppl; 2010; (190):44-50. PubMed ID: 20586735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.